Shares Of Glenmark Pharma Added 1.5 percent In The Opening Trade On Tuesday

Shares of Glenmark Pharma added 1.5 percent in the opening trade on Tuesday as company received final approval from USFDA for Colesevelam Hydrochloride.

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet.

Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc.

For more information ✆ +91 9111-179961 or Visit Dollar Advisory